A few large companies are beginning to partner with payers to develop data on outcomes that can be mutually beneficial. Selected examples below. (A) Deal with Medco Health Solutions Inc. prior to acquisition by Express Scripts Holding Co. (NASDAQ:ESRX) in April 2012; (B) Warner Chilcott plc (NASDAQ:WCRX) acquired the pharmaceutical business of Procter & Gamble Co. (NYSE:PG) in 2009; Sources: BioCentury reporting; company press releases



Partnership details


Sharing/developing data

Humana Inc. (NYSE:HUM)

Boehringer Ingelheim GmbH

Jointly design projects to develop data, insights and care interventions for chronic obstructive pulmonary disease (COPD) and cardiovascular diseases


Humana Inc. (NYSE:HUM)

Eli Lilly and Co. (NYSE:LLY)

Jointly study the impact of interventions on outcomes, adherence programs, disease management and pharmacoeconomics. The initial project will investigate factors associated with higher healthcare costs in Type II diabetes patients.